Introduction
An implant is defi ned as a medical device made from one or more biomaterials that is intentionally placed within the body, either totally or partially buried beneath an epithelial surface. Biomaterials by defi nation is a non-drug substance suitable for inclusion in system which augment or replace the function of bodily tissue or organ. From as early as a century ago artifi cial material and device have been developed to a point where they can replace various component of the human body.
There are three terms in which a biomaterial may be described in or classifi ed into representing the tissues responses. These are bioinert, bioresorbable and bioactive, which are well covered in range of literature. More effective means of affi xing hard tissue implants for augmentation or replacement involves three elements: the material system, the biologic profi le and device design. Changes in biologic responses and device design have been the direct result of advances in material science.
Bioceramics primarily have provided the research and dental clinical professionals with new substances of interest for over last 2 decades. Various formulations of these materials have been conceived on the basis of their chemical similarity to bone.
Bioceramics
Bioceramics have structural function as joint or tissue replacement, can be used as coatings to improve the biocompatibility of metal implants and can function as resorbable lattices which provide temporary structures and a framework that is dissolved, replaced as the body rebuilds tissue. The thermal and chemical stability of ceramics, there high strength, wear resistance and durability all contribute to making ceramics good candidate material for surgical implants.
Bioceramics are non-toxic can be bioinert, bioactive that is durable material which can undergo interfacial interactions with surrounding tissue, they can be also biodegradable, soluble or resorbable. Sugar and proteins can bind to ceramics. Blood vessels for example can penetrate some ceramic prosthetics and bone materials can eventually begin to replace them. Bioceramics fulfi ll a unique function as biomedical materials.
History of Bioceramics
Firstly widely evaluated bioceramic was common plaster of paris (CaSO 4 , H 2 O).
Dressman published fi rst report on use of plaster of paris to repair bone defect in 1892. The modern era of bioceramic was traced by Smith's successful study of ceramic bone substitute named Cerosium in 1963, Cerosium is composed of porous aluminate ceramic impregnated with a epoxy resin.
The use of bioceramics in human surgery began in 1980s. First commercially available hydroxyapatite coated implants were seen in 1980s.
In 1997 Chevalier and coworkers reported that the coeffi cient of friction between alumina and zirconia is very low. The most devastating historical event was the introduction of 'TH-Zirconia' implants in 1998. It has been reported that over 400,000 Zirconia hip joint femoral heads have been implanted since 1985 until 2001.
Bioceramics are available as

Microspheres Thin layers or coatings on a metallic implants Porous networks
Composites with a polymer component Large well polished surface. 
Types of Bioceramics
Functions of Bioceramics
Bioceramics satisfy needs as diverse as follows:
They have low co-effi cient of friction for lubricating surfaces in joint prostheses Can be placed on surfaces on heart valves that avoid blood clotting They act as a material that stimulate bone growth.
Bioactive
Bioglasses/Glass Ceramics
Since discovery of the bioglasses, which bond to living tissue by Hench and Wilson, various kinds of bioactive glasses and glass ceramics with different functions such as high mechanical strength and fast setting ability have been developed. The glasses that have been investigated for implantation are primarily based on silica (SiO 2 ), which may contain small amounts of other crystalline phases.
Since the discovery of stable SiO 2 −Na 2 O−CaO ceramic formulations several thousand years ago, most silicate ceramics used by man have an SiO 2 content of 65 wt% or more. These SiO 2 −Na 2 O−CaO ceramics are more commonly called glass. These 65% silica glass are bioinert, also they are weak and shatter easily.
The fi rst bioactive glass was invented in 1971 [3] . Composition of 45S5 Bioglass is -45% SiO 2 , 24.5% CaO, 24.5% NaO 2 , unfortunately it is very weak and brittle. The addition of 6% P 2 O 5 by weight makes the glass extremely bioactive. Hench, and Vrouwenvelder et al. suggested that bioglass ® 45S5 has greater osteoblastic activity as compared to hydroxyapatite. Li et al. prepared glass ceramics with differing degrees of crystallinity and found that the amount of glassy phase remaining directly infl uences the formation of an apatite layer, with total inhibition when the glassy phase constituted less than about 5 wt%.
Bio-Resorbable
Hydroxyapatite
Synthetic hydroxyapatite Ca 10 (PO 4 ) 6 (OH) 2 was accepted as a potential biomaterial that forms a strong chemical bond with bone in vivo [4] . It was initially used for repair of residual ridge resorption in 1970s and was fi rstly declared as successful implant material in 1988 at North America.
Hydroxyapatite is chemically similar to the mineral component of bones and hard tissues in mammals. It is one of few materials that are classed as bioactive.
Properties
The ability to integrate in bone structures and support bone in growth, without breaking down or dissolving (i.e. it is bioactive) Hydroxyapatite is a thermally unstable compound, decomposing at temperature from about 800-1,200°C depending on its stoichiometry It does not have the mechanical strength to enable it to succeed in long-term load bearing applications
